Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Completed
Blood and Marrow Transplant Clinical Trials Network
Phase 3
2003-11-01
The study is designed as a Phase III, randomized, double-blind, multicenter, prospective,
comparative study of fluconazole versus voriconazole for the prevention of fungal infections
in allogeneic transplant recipients. Recipients will be stratified by center and donor type
(sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm
in a 1:1 ratio.
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Completed
National Cancer Institute (NCI)
Phase 3
2003-11-01
The study is designed as a Phase III, randomized, double-blind, multicenter, prospective,
comparative study of fluconazole versus voriconazole for the prevention of fungal infections
in allogeneic transplant recipients. Recipients will be stratified by center and donor type
(sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm
in a 1:1 ratio.
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3
2003-11-01
The study is designed as a Phase III, randomized, double-blind, multicenter, prospective,
comparative study of fluconazole versus voriconazole for the prevention of fungal infections
in allogeneic transplant recipients. Recipients will be stratified by center and donor type
(sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm
in a 1:1 ratio.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
